Back to the Lab! Improving R&D Productivity and Efficiency with LIMS and ELNs
NEW YORK, Nov. 8, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Back to the Lab! Improving R&D Productivity and Efficiency with LIMS and ELNs
Introduction
The rigorous R&D processes of pharma and biotech have provided them with a wealth of data, documents and knowledge, but this information is often held in organizational silos, paper laboratory notebooks and disparate IT systems, rendering them virtually useless. Therefore, life sciences companies are implementing LIMS and ELNs to remove the silos and connect R&D groups across the enterprise.
Scope
*Identifies the key forces driving the adoption of data and knowledge management solutions by the life sciences industry
*Analyzes the crucial issues that will impede the use of LIMS and ELNs
*Discusses the benefits of using LIMS and ELNs and how to get the most out of the systems
*Offers insight into how IT vendors can improve their products to target pharma and biotech companies
Highlights
To enable data-sharing, life sciences companies first need to develop a corporate-wide data management strategy that allows information to seamlessly move across the enterprise. Once a clear plan of action is in place, companies should look closer at the technologies that will enable data and knowledge management, particularly LIMS and ELNs.
LIMS and ELNs offer many tangible and intangible benefits, such as increased R&D productivity and efficiency, enhanced data and knowledge sharing, reduced risk, and adherence to regulatory compliance. If life sciences companies are smart about how they use their software, they are bound to experience unquestionable operational improvements.
Data management software vendors are providing next-generation products with added informatics functionality, but it is unlikely that suppliers will ever be able to provide an all-encompassing lab informatics solution. They should look to offer an integrated laboratory informatics platform made available through partnerships with other vendors.
Reasons to Purchase
*Validate your market messaging and positioning in the pharmaceutical industry
*Identify strategies that will increase adoption of LIMS and ELNs by life sciences companies
*Understand the trends that are shaping the future of pharma data and knowledge management
SUMMARY 1
Catalyst 1
Ovum View 1
Key Messages 2
Data management software must be implemented to remove R&D silos and enable collaboration 2
A corporate data and knowledge management strategy must be in place before technology is adopted 3
A paperless environment is just an added benefit of ELN adoption, not the primary benefit 3
The future of laboratory informatics needs to be an integrated platform 3
TABLE OF CONTENTS 5
Table of FiguresMARKET CONTEXT: THE STATE OF THE LIMS AND ELN MARKET 5
MARKET CONTEXT: THE STATE OF THE LIMS AND ELN MARKET 6
Cheat sheet: differentiating between LIMS and ELNs 6
Traditional LIMS is all about the sample and laboratory automation 6
An ELN's core function is to replace paper lab notebooks 7
The ELN market is divided 7
LIMS + ELN + analytics = integrated laboratory informatics platform 7
Although the LIMS market is mature, new use cases are emerging 8
The development of best practices facilitates the development of COTS LIMS 9
Enterprise-wide LIMS is what pharma really needs 9
The ELN market is set to grow as knowledge management becomes a priority 10
The millennial generation of scientists will drive adoption of ELNs 11
ELNs get a makeover 11
Recession and lack of budget can be excuses for only so long 12
Senior management and end users have different views on which IT solution is best 12
BUSINESS FOCUS: INCREASING EFFICIENCY THROUGH DATA MANAGEMENT 15
Data management software must be implemented to remove R&D silos 15
LIMS and ELNs are crucial to an industry undergoing rapid globalization 16
Laboratory informatics facilitates collaboration required for translational medicine 17
LIMS and ELNs help track progress of research studies and make better sense of the data 17
A paperless environment is simply an added benefit, not the primary benefit 18
ELN should stand for efficient laboratory notebook 19
Paper can be destroyed much faster than a server 19
ELNs offer better options for long-term archiving and retaining of information 19
A data and knowledge repository is a scientist's best friend 20
What's the preference: illegible handwriting or typed documentation? 20
TECHNOLOGY FOCUS: EVOLUTION OF THE LABORATORY INFORMATICS PLATFORM 21
As a hefty investment, LIMS better deliver 21
LIMS has come a long way since its conception 22
Out with costly customizations, in with (relatively) easy configurations 23
Enterprise-wide deployment needs to ensure specific use cases are still possible 24
Can an ERP system do the same thing as a LIMS? 24
ELNs must retain paper's positive attributes and remove the negative ones 25
A new data entry system should be intuitive and easy to use 25
ELNs need to cater to different disciplines and applications 25
An ELN is useless if it cannot integrate with other IT systems 25
The future of laboratory informatics needs to be an integrated platform 26
An integrated informatics platform requires partnerships between LIMS and ELN vendors 26
The R&D LIMS and ELN space is crowded, but a few vendors stand out 26
CambridgeSoft 27
GenoLogics 27
IDBS 28
Sapio Sciences 28
Symyx 29
Thermo Fisher Scientific 29
RECOMMENDATIONS 31
Recommendations for pharma and biotech enterprises 31
Develop an organizational data and knowledge management strategy before technology adoption 31
Match company needs to IT, not vice versa 32
Do not over-emphasize hard ROI 32
Recommendations for vendors 33
Listen to the customers and help them understand what IT solutions best meet their needs 33
Form partnerships with other software vendors to provide a laboratory informatics platform 33
Be active in the creation of standards for R&D data exchange 34
APPENDIX 35
Ask the analyst 35
Definitions 35
Further reading 35
Methodology 36
Disclaimer 36
List of Figures
Figure 1: Level of adoption of LIMS within the pharma and biotech industries 9
Figure 2: Level of adoption of ELNs within the pharma and biotech industries 11
Figure 3: Obstacles IT decision-makers face when trying to implement a LIMS 13
Figure 4: Obstacles IT decision-makers face when trying to implement an ELN 14
Figure 5: Siloed R&D departments and IT systems restrict data management 16
Figure 6: Traditional R&D approach versus translational medicine research 18
Figure 7: After ERP, the largest percentage of the IT budget is allocated to LIMS 22
Figure 8: For the money invested, life sciences companies expect a feature-rich LIMS 23
Figure 9: Organizational goals and strategy need to be determined before solutions are implemented 32
To order this report:
Pharmaceutical Industry: Back to the Lab! Improving R&D Productivity and Efficiency with LIMS and ELNs
Check our Company Profile, SWOT and Revenue Analysis!
Contact: |
|
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article